A groundbreaking antiviral pill called JNJ-1802, developed by Janssen, a subsidiary of Johnson & Johnson, has shown remarkable potential in the fight against dengue fever. Dengue is a vi… Read More
The medication functions by inhibiting the activity of two viral proteins, which hinders the virus’s ability to replicate. Importantly, all participants in the trial experienced good t… Read More
(CTN News) – As a result of a small human challenge trial of its dengue fever medication, Johnson & Johnson has reported encouraging results. In spite of the fact that dengue is a… Read More
To revist this article, visit My Profile, then View saved stories.To revist this article, visit My Profile, then View saved stories.Lux AlptraumIn mid-September, the New York Times Opinion s… Read More